{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:23:42Z","timestamp":1794273822352,"version":"4.9.0"},"reference-count":89,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHN 959\/6-1"],"award-info":[{"award-number":["SCHN 959\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHN959\/7-1"],"award-info":[{"award-number":["SCHN959\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHN959\/8-1"],"award-info":[{"award-number":["SCHN959\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO5002"],"award-info":[{"award-number":["KFO5002"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WI 6148\/1-1"],"award-info":[{"award-number":["WI 6148\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70116474"],"award-info":[{"award-number":["70116474"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115444"],"award-info":[{"award-number":["70115444"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022790","name":"Hector Stiftung II","doi-asserted-by":"publisher","award":["M2408"],"award-info":[{"award-number":["M2408"]}],"id":[{"id":"10.13039\/501100022790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["499404771"],"award-info":[{"award-number":["499404771"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["442069358"],"award-info":[{"award-number":["442069358"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains a formidable clinical challenge. Next-generation protein arginine methyltransferase 5 (PRMT5) inhibitors show promising clinical results in a subset of PDACs with codeletion of the tumor-suppressor CDKN2A and the methylthioadenosine phosphorylase (MTAP) gene, but resistance limits their efficacy. Our study suggests that compensatory spliceosomal reprogramming contributes to adaptation to PRMT5 inhibition. Through comprehensive molecular profiling, we demonstrate that PRMT5 inhibitors induce upregulation of RNA-binding proteins, including RNA-binding protein 39 (RBM39). We investigated whether this response could be therapeutically leveraged by combining PRMT5 inhibition with indisulam-mediated RBM39 degradation, which yielded synergistic activity in cellular model systems. The combination strategy significantly enhanced apoptotic cell death and suppressed tumor outgrowth in resistance assays compared with single-agent treatments. Multiomics analysis revealed concomitant suppression of DNA repair and metabolic pathways. Collectively, our work support spliceosomal rewiring as a candidate adaptive response to PRMT5 inhibition and nominates RBM39 as a candidate therapeutic vulnerability, thereby supporting further evaluation of dual targeting of the splicing machinery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Our study suggests that compensatory spliceosomal reprogramming occurs in response to PRMT5 inhibition. We investigated this vulnerability by combining PRMT5 inhibition with indisulam-mediated RBM39 degradation, which yielded synergistic antitumor activity in selected cellular PDAC models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0670","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:43:18Z","timestamp":1786570998000},"page":"2039-2055","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting PRMT5 Inhibitor\u2013Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7138-4360","authenticated-orcid":false,"given":"Valentina","family":"Spielmann","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-3054","authenticated-orcid":false,"given":"Jonas","family":"Buchloh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4006-4369","authenticated-orcid":false,"given":"Selen","family":"Selcen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-9026","authenticated-orcid":false,"given":"Carolin","family":"Schneider","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0495-3012","authenticated-orcid":false,"given":"Shaishavi","family":"Jansari","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 2 Department of Gynecology and Obstetrics, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-6623","authenticated-orcid":false,"given":"Xin","family":"Fang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-3796","authenticated-orcid":false,"given":"Ningjun","family":"Duan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9346-7458","authenticated-orcid":false,"given":"Engin","family":"Demirdizen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0062-8685","authenticated-orcid":false,"given":"Lukas","family":"Krau\u00df","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1588-6205","authenticated-orcid":false,"given":"Jessica","family":"Eggert","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6346-5206","authenticated-orcid":false,"given":"Geraldine","family":"Siegfried","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bordeaux 3 Bordeaux Institute of Oncology (BRIC)-UMR1312, , Bordeaux, France."},{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bordeaux 4 XenoFish, , Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3952-607X","authenticated-orcid":false,"given":"Sandrine","family":"Fedou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bordeaux 3 Bordeaux Institute of Oncology (BRIC)-UMR1312, , Bordeaux, France."},{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bordeaux 4 XenoFish, , Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-8166","authenticated-orcid":false,"given":"Christof","family":"Lenz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 5 Department of Clinical Chemistry, , G\u00f6ttingen, Germany."},{"name":"6Bioanalytical Mass Spectrometry Group, Max Planck Institute for Multidisciplinary Sciences, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5969-1012","authenticated-orcid":false,"given":"Lena","family":"Wieland","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-1018","authenticated-orcid":false,"given":"Lena-Christin","family":"Conradi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."},{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 7 Clinical Research Unit 5002, KFO5002, , G\u00f6ttingen, Germany."},{"name":"8CCC-N (Comprehensive Cancer Center Lower Saxony), G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-5639","authenticated-orcid":false,"given":"Maximilian","family":"Reichert","sequence":"additional","affiliation":[{"name":"9Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, Munich, Germany."},{"name":"10Translational Pancreatic Research Cancer Center, Medical Clinic and Polyclinic II, Klinikum Rechts Der Isar, Technical University Munich, Munich, Germany."},{"id":[{"id":"https:\/\/ror.org\/02kkvpp62","id-type":"ROR","asserted-by":"publisher"}],"name":"Technical University of Munich 11 Center for Protein Assemblies (CPA), , Garching, Germany."},{"name":"12Center for Organoid Systems and Tissue Engineering (COS), Technical University Munich, Garching, Germany."},{"name":"13German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University Hospital Klinikum rechts der Isar, Munich, Germany."},{"name":"14DEFEAT-PDAC \u2013 Decoding and Targeting the PDAC Ecosystem \u2013 a German Pancreatic Cancer Alliance (GPCA) Consortium \u2013 partner site Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-8571","authenticated-orcid":false,"given":"Volker","family":"Ellenrieder","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 7 Clinical Research Unit 5002, KFO5002, , G\u00f6ttingen, Germany."},{"name":"8CCC-N (Comprehensive Cancer Center Lower Saxony), G\u00f6ttingen, Germany."},{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 15 Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-1526","authenticated-orcid":false,"given":"Michael","family":"Ghadimi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."},{"name":"8CCC-N (Comprehensive Cancer Center Lower Saxony), G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-5362","authenticated-orcid":false,"given":"Marian","family":"Grade","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."},{"name":"8CCC-N (Comprehensive Cancer Center Lower Saxony), G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-1291","authenticated-orcid":false,"given":"Elisabeth","family":"Hessmann","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 7 Clinical Research Unit 5002, KFO5002, , G\u00f6ttingen, Germany."},{"name":"8CCC-N (Comprehensive Cancer Center Lower Saxony), G\u00f6ttingen, Germany."},{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 15 Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-0384","authenticated-orcid":false,"given":"Abdel-Majid","family":"Khatib","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bordeaux 3 Bordeaux Institute of Oncology (BRIC)-UMR1312, , Bordeaux, France."},{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bordeaux 4 XenoFish, , Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-6219","authenticated-orcid":false,"given":"Christian J.","family":"Braun","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05591te55","id-type":"ROR","asserted-by":"publisher"}],"name":"LMU Munich 16 Department of Pediatrics, Dr. von Hauner Children\u2019s Hospital, University Hospital, , Munich, Germany."},{"name":"17Department of Pediatrics, Goethe University Frankfurt, Frankfurt, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-6998","authenticated-orcid":false,"given":"Florian","family":"Wegwitz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 2 Department of Gynecology and Obstetrics, , G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-0210","authenticated-orcid":false,"given":"Dieter","family":"Saur","sequence":"additional","affiliation":[{"name":"13German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University Hospital Klinikum rechts der Isar, Munich, Germany."},{"name":"14DEFEAT-PDAC \u2013 Decoding and Targeting the PDAC Ecosystem \u2013 a German Pancreatic Cancer Alliance (GPCA) Consortium \u2013 partner site Munich, Munich, Germany."},{"name":"18Institute for Translational Cancer Research and Experimental Cancer Therapy, Technical University Munich, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-0872","authenticated-orcid":false,"given":"Matthias","family":"Wirth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."},{"name":"19Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."},{"name":"20Max-Delbr\u00fcck-Center for Molecular Medicine, Berlin, Germany."},{"name":"21German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-4508","authenticated-orcid":false,"given":"G\u00fcnter","family":"Schneider","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 1 Department of General, Visceral and Pediatric Surgery, , G\u00f6ttingen, Germany."},{"id":[{"id":"https:\/\/ror.org\/021ft0n22","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center G\u00f6ttingen 7 Clinical Research Unit 5002, KFO5002, , G\u00f6ttingen, Germany."},{"name":"8CCC-N (Comprehensive Cancer Center Lower Saxony), G\u00f6ttingen, Germany."},{"name":"18Institute for Translational Cancer Research and Experimental Cancer Therapy, Technical University Munich, Munich, Germany."},{"name":"22DEFEAT-PDAC \u2013 Decoding and Targeting the PDAC Ecosystem \u2013 a German Pancreatic Cancer Alliance (GPCA) Consortium \u2013 partner site G\u00f6ttingen, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026083123584263200_bib1","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","article-title":"Cellular pathways influenced by protein arginine methylation: implications for cancer","volume":"81","author":"Xu","year":"2021","journal-title":"Mol Cell"},{"key":"2026083123584263200_bib2","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.tranon.2025.102366","article-title":"PRMT5 inhibitors: therapeutic potential in pancreatic cancer","volume":"55","author":"Schneider","year":"2025","journal-title":"Transl Oncol"},{"key":"2026083123584263200_bib3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12964-019-0344-4","article-title":"PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7\/cMyc axis","volume":"17","author":"Qin","year":"2019","journal-title":"Cell Commun Signal"},{"key":"2026083123584263200_bib4","doi-asserted-by":"publisher","first-page":"e151353","DOI":"10.1172\/jci.insight.151353","article-title":"Epigenetic drug screening defines a PRMT5 inhibitor sensitive pancreatic cancer subtype","volume":"7","author":"Orben","year":"2022","journal-title":"JCI Insight"},{"key":"2026083123584263200_bib5","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/jcmm.14894","article-title":"PRMT5 promotes epithelial-mesenchymal transition via EGFR-\u03b2-catenin axis in pancreatic cancer cells","volume":"24","author":"Ge","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2026083123584263200_bib6","doi-asserted-by":"publisher","first-page":"e114558","DOI":"10.15252\/embj.2023114558","article-title":"MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression","volume":"42","author":"Sun","year":"2023","journal-title":"EMBO J"},{"key":"2026083123584263200_bib7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41419-024-07145-z","article-title":"The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment","volume":"15","author":"Feng","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026083123584263200_bib8","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026083123584263200_bib9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aad5214","article-title":"MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science"},{"key":"2026083123584263200_bib10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"key":"2026083123584263200_bib11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.celrep.2016.03.043","article-title":"MTAP deletions in cancer create vulnerability to targeting of the MAT2A\/PRMT5\/RIOK1 axis","volume":"15","author":"Marjon","year":"2016","journal-title":"Cell Rep"},{"key":"2026083123584263200_bib12","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","article-title":"MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer","volume":"13","author":"Engstrom","year":"2023","journal-title":"Cancer Discov"},{"key":"2026083123584263200_bib13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1021\/acs.jmedchem.1c01900","article-title":"Fragment-based discovery of MRTX1719, a synthetic lethal inhibitor of the PRMT5\u2022MTA complex for the treatment of MTAP-deleted cancers","volume":"65","author":"Smith","year":"2022","journal-title":"J Med Chem"},{"key":"2026083123584263200_bib14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1158\/2159-8290.CD-24-0887","article-title":"AMG 193, a clinical stage MTA-cooperative PRMT5 inhibitor, drives antitumor activity preclinically and in patients with MTAP-deleted cancers","volume":"15","author":"Belmontes","year":"2025","journal-title":"Cancer Discov"},{"key":"2026083123584263200_bib15","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1021\/acs.jmedchem.4c03067","article-title":"Discovery of TNG462: a highly potent and selective MTA-cooperative PRMT5 inhibitor to target cancers with MTAP deletion","volume":"68","author":"Cottrell","year":"2025","journal-title":"J Med Chem"},{"key":"2026083123584263200_bib16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.annonc.2024.08.2339","article-title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase 1 dose exploration","volume":"35","author":"Rodon","year":"2024","journal-title":"Ann Oncol"},{"key":"2026083123584263200_bib17","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1200\/jco.2025.43.16_suppl.3011","article-title":"BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del): clinical update and first report of pharmacokinetics (PK) and pharmacodynamic (PD) analyses from CA240-0007","volume":"43","author":"Arbour","year":"2025","journal-title":"J Clin Oncol"},{"key":"2026083123584263200_bib18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41568-025-00824-9","article-title":"Acquired resistance in cancer: towards targeted therapeutic strategies","volume":"25","author":"Soragni","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"2026083123584263200_bib19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","article-title":"Cellular adaptation to cancer therapy along a resistance continuum","volume":"631","author":"Fran\u00e7a","year":"2024","journal-title":"Nature"},{"key":"2026083123584263200_bib20","doi-asserted-by":"publisher","first-page":"102961","DOI":"10.1016\/j.esmoop.2024.102961","article-title":"A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations","volume":"9","author":"Rodon","year":"2024","journal-title":"ESMO Open"},{"key":"2026083123584263200_bib21","article-title":"Vopimetostat clinical update","author":"TANGO Therapeutics","year":"2025"},{"key":"2026083123584263200_bib22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.chembiol.2016.06.007","article-title":"Rational design of a GFP-based fluorogenic caspase reporter for imaging apoptosis in vivo","volume":"23","author":"To","year":"2016","journal-title":"Cell Chem Biol"},{"key":"2026083123584263200_bib23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41420-025-02662-y","article-title":"Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform","volume":"11","author":"Selcen","year":"2025","journal-title":"Cell Death Discov"},{"key":"2026083123584263200_bib24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.gastro.2023.10.026","article-title":"An NFATc1\/SMAD3\/cJUN complex restricted to SMAD4-deficient pancreatic cancer guides rational therapies","volume":"166","author":"Hasselluhn","year":"2024","journal-title":"Gastroenterology"},{"key":"2026083123584263200_bib25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/1878-0261.13725","article-title":"KRASG12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening","volume":"19","author":"Tapia Contreras","year":"2025","journal-title":"Mol Oncol"},{"key":"2026083123584263200_bib26","doi-asserted-by":"publisher","first-page":"108711","DOI":"10.1016\/j.isci.2023.108711","article-title":"In situ modeling of acquired resistance to RTK\/RAS-pathway-targeted therapies","volume":"27","author":"Sealover","year":"2024","journal-title":"iScience"},{"key":"2026083123584263200_bib27","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/ueg2.70086","article-title":"Pan-ERBB inhibitors synergize with KRAS inhibitors in rectal cancer","volume":"13","author":"Buchloh","year":"2025","journal-title":"United Eur Gastroenterol J"},{"key":"2026083123584263200_bib28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ijc.28429","article-title":"STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo","volume":"134","author":"Spitzner","year":"2014","journal-title":"Int J Cancer"},{"key":"2026083123584263200_bib29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2026083123584263200_bib30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"2026083123584263200_bib31","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026083123584263200_bib32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026083123584263200_bib33","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"2026083123584263200_bib34","doi-asserted-by":"publisher","first-page":"W515","DOI":"10.1093\/nar\/gkaa306","article-title":"GeneTrail 3: advanced high-throughput enrichment analysis","volume":"48","author":"Gerstner","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026083123584263200_bib35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026083123584263200_bib36","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Proteogenomic characterization of pancreatic ductal adenocarcinoma","volume":"184","author":"Cao","year":"2021","journal-title":"Cell"},{"key":"2026083123584263200_bib37","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026083123584263200_bib38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"2026083123584263200_bib39","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41591-022-01829-9","article-title":"Sotigalimab and\/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial","volume":"28","author":"Padr\u00f3n","year":"2022","journal-title":"Nat Med"},{"key":"2026083123584263200_bib40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41588-021-00791-5","article-title":"The NCI genomic data commons","volume":"53","author":"Heath","year":"2021","journal-title":"Nat Genet"},{"key":"2026083123584263200_bib41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2026083123584263200_bib42","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.can-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"2026083123584263200_bib43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41596-023-00944-2","article-title":"rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data","volume":"19","author":"Wang","year":"2024","journal-title":"Nat Protoc"},{"key":"2026083123584263200_bib44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","article-title":"Single-pot, solid-phase-enhanced sample preparation for proteomics experiments","volume":"14","author":"Hughes","year":"2019","journal-title":"Nat Protoc"},{"key":"2026083123584263200_bib45","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","article-title":"diaPASEF: parallel accumulation\u2013serial fragmentation combined with data-independent acquisition","volume":"17","author":"Meier","year":"2020","journal-title":"Nat Methods"},{"key":"2026083123584263200_bib46","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/nmeth.2702","article-title":"Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition","volume":"10","author":"Lambert","year":"2013","journal-title":"Nat Methods"},{"key":"2026083123584263200_bib47","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1021\/acs.jproteome.5b00543","article-title":"The use of variable Q1 isolation windows improves selectivity in LC\u2013SWATH\u2013MS acquisition","volume":"14","author":"Zhang","year":"2015","journal-title":"J Proteome Res"},{"key":"2026083123584263200_bib48","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026083123584263200_bib49","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41419-023-06157-5","article-title":"RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer","volume":"14","author":"Prokakis","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026083123584263200_bib50","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1038\/s41598-023-50677-1","article-title":"Apela promotes blood vessel regeneration and remodeling in zebrafish","volume":"14","author":"Nys","year":"2024","journal-title":"Sci Rep"},{"key":"2026083123584263200_bib51","doi-asserted-by":"publisher","first-page":"1278630","DOI":"10.3389\/fimmu.2023.1278630","article-title":"Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-\u03baB and calcium activity repression","volume":"14","author":"Pernot","year":"2024","journal-title":"Front Immunol"},{"key":"2026083123584263200_bib52","doi-asserted-by":"publisher","first-page":"eaal3755","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"2026083123584263200_bib53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nchembio.2363","article-title":"Selective degradation of splicing factor CAPER\u03b1 by anticancer sulfonamides","volume":"13","author":"Uehara","year":"2017","journal-title":"Nat Chem Biol"},{"key":"2026083123584263200_bib54","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1111\/bph.15331","article-title":"RNA-binding motif protein 39 (RBM39): an emerging cancer target","volume":"179","author":"Xu","year":"2022","journal-title":"Br J Pharmacol"},{"key":"2026083123584263200_bib55","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2017.08.018","article-title":"Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma","volume":"32","author":"Braun","year":"2017","journal-title":"Cancer Cell"},{"key":"2026083123584263200_bib56","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-25-1507","article-title":"Combination of the MTA-cooperative PRMT5 inhibitor BMS-986504 and KRAS inhibitors is an effective treatment strategy for MTAP-deleted KRAS-mutant pancreatic cancer","volume":"85","author":"Drizyte-Miller","year":"2025","journal-title":"Cancer Res"},{"key":"2026083123584263200_bib57","doi-asserted-by":"publisher","first-page":"e70150","DOI":"10.1002\/mco2.70150","article-title":"PRMT5 promotes pancreatic cancer tumorigenesis via positive PRMT5\/C-Myc feedback loop","volume":"6","author":"Yang","year":"2025","journal-title":"MedComm"},{"key":"2026083123584263200_bib58","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/1535-7163.MCT-16-0050","article-title":"Concepts to target MYC in pancreatic cancer","volume":"15","author":"Wirth","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2026083123584263200_bib59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trecan.2015.12.002","article-title":"MYC: a stratification marker for pancreatic cancer therapy","volume":"2","author":"Wirth","year":"2016","journal-title":"Trends Cancer"},{"key":"2026083123584263200_bib60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13550-021-00843-1","article-title":"Rationale for MYC imaging and targeting in pancreatic cancer","volume":"11","author":"Schneider","year":"2021","journal-title":"EJNMMI Res"},{"key":"2026083123584263200_bib61","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/gutjnl-2018-317856","article-title":"SUMO pathway inhibition targets an aggressive pancreatic cancer subtype","volume":"69","author":"Biederst\u00e4dt","year":"2020","journal-title":"Gut"},{"key":"2026083123584263200_bib62","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/1878-0261.12835","article-title":"Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC","volume":"14","author":"Lankes","year":"2020","journal-title":"Mol Oncol"},{"key":"2026083123584263200_bib63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature14351","article-title":"MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis","volume":"523","author":"Koh","year":"2015","journal-title":"Nature"},{"key":"2026083123584263200_bib64","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41388-024-03264-1","article-title":"PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells","volume":"44","author":"Gillespie","year":"2025","journal-title":"Oncogene"},{"key":"2026083123584263200_bib65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2026083123584263200_bib66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"2026083123584263200_bib67","doi-asserted-by":"publisher","first-page":"102973","DOI":"10.1016\/j.ctrv.2025.102973","article-title":"Medical management of pancreatic cancer: from personalization to broadening treatment strategies","volume":"138","author":"Dusetti","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"2026083123584263200_bib68","doi-asserted-by":"publisher","first-page":"104535","DOI":"10.1016\/j.esmoop.2025.104535","article-title":"Pan-cancer clinical and molecular landscape of MTAP deletion in nationwide and international comprehensive genomic data","volume":"10","author":"Ikushima","year":"2025","journal-title":"ESMO Open"},{"key":"2026083123584263200_bib69","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1158\/0008-5472.CAN-25-1464","article-title":"CRISPR-drug combinatorial screening identifies effective combination treatments for MTAP-deleted cancer","volume":"85","author":"Knoll","year":"2025","journal-title":"Cancer Res"},{"key":"2026083123584263200_bib70","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","article-title":"The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond","volume":"72","author":"Stopa","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"2026083123584263200_bib71","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1128\/MCB.21.24.8289-8300.2001","article-title":"The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins","volume":"21","author":"Friesen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2026083123584263200_bib72","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/s0960-9822(01)00592-9","article-title":"Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln","volume":"11","author":"Meister","year":"2001","journal-title":"Curr Biol"},{"key":"2026083123584263200_bib73","doi-asserted-by":"publisher","first-page":"17122","DOI":"10.1074\/jbc.M000300200","article-title":"The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies","volume":"275","author":"Brahms","year":"2000","journal-title":"J Biol Chem"},{"key":"2026083123584263200_bib74","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1017\/s135583820101442x","article-title":"Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B\/B\u2032 and the Sm-like protein LSm4, and their interaction with the SMN protein","volume":"7","author":"Brahms","year":"2001","journal-title":"RNA"},{"key":"2026083123584263200_bib75","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/s0962-8924(02)02371-1","article-title":"SMN-mediated assembly of RNPs: a complex story","volume":"12","author":"Meister","year":"2002","journal-title":"Trends Cell Biol"},{"key":"2026083123584263200_bib76","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1101\/gad.247361.114","article-title":"Detained introns are a novel, widespread class of post-transcriptionally spliced introns","volume":"29","author":"Boutz","year":"2015","journal-title":"Gene Dev"},{"key":"2026083123584263200_bib77","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41576-025-00836-z","article-title":"The regulation and function of post-transcriptional RNA splicing","volume":"26","author":"Choquet","year":"2025","journal-title":"Nat Rev Genet"},{"key":"2026083123584263200_bib78","doi-asserted-by":"publisher","first-page":"112965","DOI":"10.1016\/j.isci.2025.112965","article-title":"The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing","volume":"28","author":"Fowler","year":"2025","journal-title":"iScience"},{"key":"2026083123584263200_bib79","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.molcel.2021.07.019","article-title":"Molecular basis for substrate recruitment to the PRMT5 methylosome","volume":"81","author":"Mulvaney","year":"2021","journal-title":"Mol Cell"},{"key":"2026083123584263200_bib80","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"2026083123584263200_bib81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"2026083123584263200_bib82","doi-asserted-by":"publisher","first-page":"eabj5405","DOI":"10.1126\/sciadv.abj5405","article-title":"Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models","volume":"7","author":"Singh","year":"2021","journal-title":"Sci Adv"},{"key":"2026083123584263200_bib83","doi-asserted-by":"publisher","first-page":"217263","DOI":"10.1016\/j.canlet.2024.217263","article-title":"Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways","volume":"604","author":"Bojko","year":"2024","journal-title":"Cancer Lett"},{"key":"2026083123584263200_bib84","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1039\/d5mo00053j","article-title":"Network-driven identification of indisulam neo-substrates for targeted protein degradation","volume":"21","author":"Jarnuczak","year":"2025","journal-title":"Mol Omics"},{"key":"2026083123584263200_bib85","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","article-title":"Pharmacologic modulation of RNA splicing enhances anti-tumor immunity","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"2026083123584263200_bib86","doi-asserted-by":"publisher","first-page":"e009600","DOI":"10.1136\/jitc-2024-009600","article-title":"MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors","volume":"12","author":"Chen","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026083123584263200_bib87","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1038\/s41467-025-63979-x","article-title":"RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity","volume":"16","author":"Singh","year":"2025","journal-title":"Nat Commun"},{"key":"2026083123584263200_bib88","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"key":"2026083123584263200_bib89","doi-asserted-by":"publisher","first-page":"116784","DOI":"10.1016\/j.celrep.2025.116784","article-title":"Exploiting the polypharmacology of alectinib for synergistic RNA splicing disruption with RBM39 degraders","volume":"45","author":"Ma","year":"2026","journal-title":"Cell Rep"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0670\/3821031\/crc-25-0670.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/9\/2039\/3825721\/crc-25-0670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/9\/2039\/3825721\/crc-25-0670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:58:48Z","timestamp":1788235128000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/9\/2039\/787739\/Targeting-PRMT5-Inhibitor-Induced-Adaptation-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0670","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.33401000","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400979","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400967","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400988","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400994","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400982","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400970","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33401003","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400991","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400976","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400964","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400997","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400985","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33400973","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8685380","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}